Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Rodent studies lasting up to 90 days show no significant adverse events at doses up to 10 mg/kg, but no human safety data exist for BPC-157 in any indication, including gastroparesis
This feature allows researchers to input their desired microgram or milligram dose and instantly view the draw volume required
500-1,000 mg per session in higher-dose clinic protocols
Mechanisms : Effective in reducing adhesions and enhancing vascular health, it ensures an optimal environment for repair processes ( 6, 8, 10 )
PubMed search Related Products BPC-157 + TB-500 20mg co-lyophilised 1:1 blend for combination research BPC-157 10mg standalone, for independent BPC-157 dose-response work TB-500 10mg standalone, for independent TB-500 dose-response work KLOW 80mg BPC-157 + TB-500 + GHK-Cu + KPV (4-compound multi-pathway blend) GLOW 70mg GHK-Cu + TB-500 + BPC-157 (skin / regenerative tri-blend) BPC-157 UK Research Guide 2026 mechanism, purity standards, UK research compliance TB-500 / Thymosin Beta-4 Research Guide cell migration biology and protocol context
US$ 27.40
US$ 26.93
US$ 24.90